Molecular genetic tools for the identification and analysis of drug targets in Toxoplasma gondii

Current Topics in Microbiology and Immunology

Volumn 219, Issue , 1996, Pages 247-259

  Roos, D S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG TARGETING; HUMAN; MOLECULAR GENETICS; MUTAGENESIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; REVIEW; SAFETY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

TOXOPLASMA GONDII;

EID: 0029761939     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-51014-4_22     Document Type: Review

References (39)

1. Araujo FG, Remington JS (1992) Recent advances in the search for new drugs for treatment of toxoplasmosis. Int J Antimicrob Agents 1:153-164
2. Beckers CJ, Roos DS, Donald RG, Luft BJ, Schwab JC, Cao Y, Joiner KA (1995) Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii, Implications for the target of macrolide antibiotics. J Clin invest 95:367-376
3. Black M, Seeber F, Soldati D, Kim K, Boothroyd JC (1995) Restriction enzyme-mediated integration elevates transformation frequency and enables cotransfection of Toxoplasma gondii. Mol Biochem Parasitol 74:55-63
4. Bohne W, Gross U, Ferguson DJP, Heesemann J (1995) Cloning and characterization of a bradyzoite-specifically expressed gene (HSP30/BAG1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol 16.1221-1230
5. Boothroyd JC, Black M, Kim K, Pfefferkorn ER, Seeber F, Sibley LD, Soldati D (1995). Forward and reverse genetics in the study of the obligate, intracellular parasite Toxoplasma gondii. In Adolph K (ed) Methods in Molecular Genetics. Academic, New York, pp 3-29
6. Brooks RG, Remington JS, Luft BJ (1987) Drugs used in the treatment of toxoplasmosis. Antimicrob Agents Annu 2:297-306
7. Cotrim PC, Garrity LK, Beverly SM (1994) Isolation of drug resistance genes in Leishmania major by transfection using a shuttle cosmid vector. Molecular Parasitology Meeting, 18-22 September 1994, Woods Hole, MA, abstract 125C
8. Danneman B, McCutchan JA, Israelski D, Antoniskis D, and the California Collaborative Treatment Group (1992) Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus clindamycin. Ann Int Med 116:33-43
9. Donald RGK, Roos DS (1993) Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. Proc Natl Acad Sci USA 90:11703-11707
10. Donald RGK, Carter D, Uliman B, Roos DS (1996) Insertional tagging, cloning and expression of the Toxoplasma gondii hypoxanthine -xanthine -guanine phosphoribosyltransferase gene. use as a selectable marker for stable transfection. J Biol Chem (in press)
11. Donald RGK, Roos DS (1994) Homologous recombination and gene replacement at the DHFR-TS locus in Toxoplasma gondii Mol Biochem Parasitol 63:243-253
12. Donald RGK, Roos DS (1995) Insertional mutagenesis in a protozoan parasite: Direct cloning of the uracil phosphoribosyl transferase gene from Toxoplasma gondii. Proc Natl Acad Sci USA 92:5749-5753
13. Ellis J, Griffin H, Morrison D, Johnson AM (1993) Analysis of dinucleotide frequency and codon usage in the phylum Apicomplexa Gene 126:163-170
14. Fichera ME, Bhopale MK, Roos DS (1995) In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii Antimicrob Agents Chemother 39.1530-1537
15. Haverkos HW (1987) Assessment of therapy for toxoplasma encephalitis Am J Med 82:907-914
16. High KP, Joiner KA, Handschumacher RE (1994) Isolation, cDNA sequences, and biochemical characterization of the major cyclosporin-binding proteins of Toxoplasma gondii. J Biol Chem 269:9105-9112
17. Katlama C (1991) Evaluation of the efficacy and safety of clindamycin and pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS. Eur J Clin Microbiol Infect Dis 10:189-191
18. Kim K, Soldati D, Boothroyd JC (1993) Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker. Science 262.911-914
19. Laughon BE, Allaudeen HS, Becker JM, Current WL, Feinberg J, Frenkel JK, Hafner R, Hughes WT, Laughiin CA, Meyers JD, Schrager LK, Young LS (1991) Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS J Infect Dis 164.244-251
20. Leport C, Raffi F, Katlama C, Regnier B, Saimot AG, Marche C, Vedrenne C, Vilde JL (1988) Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfonamide combination in 35 patients with the acquired immunodeficiency syndrome. Am J Med 84:94-100
21. Luft BJ, Remington JS (1992) Toxoplasmic encephalitis in AIDS. Clin Infect Dis 15:211-222
22. Mortensen R (1993) Overview of gene-targeting by homologous recombination. In: Ausubel FM (ed) Current protocols in molecular biology. Wiley, Cambridge, Chap. 9.15 1-9 15.6
23. Parent SA, Fenimore CM, Bostian KA (1985) Vector systems for the expression, analysis and cloning of DNA sequences in S. cerevisiae. Yeast 1.83-138
24. Parmley SF, Yang S, Harth G, Sibley LD, Sucharczuk A, Remington JS (1994) Molecular characterization of a 65-kilodalton Toxoplasma gondii antigen expressed abundantly in the matrix of tissue cysts. Mol Biochem Parasitol 66:283-296
25. Pashley TV, Delves CJ, Hyde JE, Sims PFG (1995) Molecular cloning and sequence analysis of the Toxoplasma gondii dihydropteroate synthase gene. Molecular Parasitology Meeting, 17-21 September 1995, Woods Hole, MA, abstract 442
26. Pfefferkorn ER (1990) Cell biology of Toxoplasma gondii. In: Wyler DJ (ed) Modern parasite biology. Freeman, New York, pp 26-50
27. Pfefferkorn ER, Borotz SE (1994) Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. Antimicrob Agents Chemother 38:31-37
28. Pfefferkorn ER, Pfefferkorn LC (1979) Quantitative studies on the mutagenesis of Toxoplasma gondii. J Parasitol 65:364-370
29. Pfefferkorn ER, Pfefferkorn LC (1980) Toxoplasma gondii: Genetic recombination between drugresistant mutants. Exp Parasitol 50:305-316
30. Ricketts AP, Pfefferkorn ER (1993) Toxoplasma gondii: Susceptibility and development of resistance to anticoccidial drugs in vitro Antimicrob Agents Chemother 37:2358-2363
31. Roos DS (1993) Primary structure of the fused dihydrofolate reductase/thymidylate synthase gene of Toxoplasma gondii. J Biol Chem 268:6269-6280
32. Roos DS, Donald RGK, Morrissette NS, Moulton ALC (1994) Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol 45:27-63
33. Sibley LD, LeBlanc AJ, Pfefferkorn ER, Boothroyd JC (1992) Generation of a restriction fragment length polymorphism linkage map for Toxoplasma gondii Genetics 132:1003-1015
34. Sibley LD, Messina M, Niesman IR (1994) Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy Proc Natl Acad Sci USA 91:5508-5512
35. Soldati D, Boothroyd JC (1993) Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii Science 260.349-352
36. Soldati D, Boothroyd JC (1995) A selector of transcription initiation in the protozoan parasite Toxoplasma gondii. Mol Cell Biol 15:87-93
37. Steigbigel NH (1990) Erythromycin, lincomycin and clindamycin. In. Mandel GL, Douglas RG Jr. Bennet JE (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York
38. Stokkermans TJW, Schwartzman JD, Keenan K, Morisette NS, Tilney LG, Roos DS. Inhibition of Toxoplasma gondii replication by dinitroaniline herbicides Exp Parasitol (in press)
39. Tenant-Flowers M, Boyle MJ, Carey D, Marriott DJ, Harkness JL, Penny R, Cooper DA (1991) Sulfadiazine desensitization in patients with AIDS and cerebral toxoplasmosis. AIDS 5:311-315